Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LUI)

Clinical and Experimental Rheumatology

Volumn 26, Issue 2, 2008, Pages 268-274

  Andrade, Rosa ^a   Sanchez, Martha L ^a   Alarcón, Graciela S ^a   Fessler, Barri J ^a   Fernández, Mónica ^a   Bertoli, Ana M ^a   Apte, Mandar ^a   Vilá, Luis M ^c   Arango, Ana M ^b   Reveille, John D ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PUERTO RICO MEDICAL SCIENCES CAMPUS   (Puerto Rico)

Author keywords

Abortions; Adverse outcome; Miscarriages; Pregnancy; Pregnancy loss; Premature births; SLE; Stillbirths

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID; HYDROXYCHLOROQUINE; PREDNISONE;

ADULT; ADVERSE OUTCOME; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG USE; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; KIDNEY DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SOCIAL STATUS; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMIC LUPUS ERYTHEMATOSUS;

ABORTION, SPONTANEOUS; ADULT; AFRICAN AMERICANS; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOCORTICOIDS; HISPANIC AMERICANS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREMATURE BIRTH; STILLBIRTH; UNITED STATES;

EID: 43349104778     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. MINTZ G, NIZ J, GUTIERREZ G, GARCIA-ALONSO A, KARCHMER S: Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 1986; 13: 732-39.
2. PETRI M: Prospective study of systemic lupus erythematosus pregnancies. Lupus 2004; 13: 688-89.
3. GEORGIOU PE, POLITI EN, KATSIMBRI P, SAKKA V, DROSOS AA: Outcome of lupus pregnancy: A controlled study. Rheumatol 2000; 39: 1014-19.
4. DHAR JP, ESSENMACHER LM, AGER JW, SOKOL RJ: Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 2005; 193: 1444-55.
5. LOCKSHIN MD, SAMMARITANO LR: Lupus pregnancy. Autoimmunity 2003; 36: 33-40.
6. UROWITZ MB, GLADMAN DD, FAREWELL VT, STEWART J, MCDONALD J: Lupus and pregnancy studies. Arthritis Rheum 1993; 36: 1392-7.
7. JONES DC, HAYSLETT JP: Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med 1996; 335: 226-32.
8. KISS E, BHATTOA HP, BEITEMBUK P, BALOGH A, SZEGEDI G: Pregnancy in women with systemic lupus erythematosus. Eur J Obstet Gynecol Reprod Biol 2002; 101: 129-34.
9. MOLAD Y, BORKOWSKI T, MONSELISE A et al.: Maternal and fetal outcome of lupus pregnancy: A prospective study of 29 pregnancies. Lupus 2005; 14: 145-51.
10. MORONI G, PONTICELLI C: Pregnancy after lupus nephritis. Lupus 2005; 14: 89-94.
11. BUYON JP, KIM MY, COPEL JA, FRIEDMAN DM: Anti-Ro/SSA antibodies and congenital heart block: Necessary but not sufficient. Arthritis Rheum 2001; 44: 1723-7.
12. RAMIREZ RR, DE LA CRUZ GP: The Hispanic population in the United States. In: Current population reports. US Census Bureau. 2002; March - www.census.gov/prod/2003pubs.
13. ALARCON GS, MCGWIN G JR, BARTOLUCCI AA et al.: Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 2001; 44: 2797-806.
14. ALARCON GS, FRIEDMAN AW, STRAATON KV et al.: Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus 1999; 8: 197-209.
15. BASTIAN HM, ROSEMAN JM, MCGWIN G JR et al.: Systemic lupus erythematosus in three ethnic groups: XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152-60.
16. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-77.
17. LIANG MH, FORTIN PR, ISENBERG DA, SNAITH L: Quantitative clinical assessment of disease activity in systemic lupus erythematosus: Progress report and research agenda. Rheumatol Int 1991; 11: 133-36.
18. WLUKA AE, LIANG MH, PARTRIDGE AJ et al.: Assessment of systemic lupus erythematosus disease activity by medical record review compared with direct standardized evaluation. Arthritis Rheum 1997; 40: 57-61.
19. HARRIS EN: Special report. The second international anti-cardiolipin standardization workshop/the Kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476-84.
20. TRIPLETT DA, BARNA LK, UNGER GA: A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant identification. Thromb Haemost 1993; 70: 787-93.
21. HAMILTON RG, HARLEY JB, BIAS WB et al.: Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arthritis Rheum 1988; 31: 496-505.
22. KRAMER MS, DEMISSIE K, YANG H, PLATT RW, SAUVE R, LISTON R: The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. J Am Med Assoc 2000; 284: 843-9.
23. FESSLER BJ, ALARCON GS, MCGWIN G JR et al.: Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum 2005; 52: 1473-80.
24. TOLOZA SMA, URIBE AG, MCGWIN G JR et al.: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXIII: Baseline predictors of vascular events. Arthritis Rheum 2004; 50: 3947-57.
25. CALVO-ALÉN J, TOLOZA S, FERNÁNDEZ M et al.: Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXV: Smoking, older age and glucocorticoid use are risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum 2005; 52: 2060-8.
26. ANDRADE RM, MCGWIN G JR, ALARCON GS et al.: Predictors of post-partum damage accrual in systemic lupus erythematosus: Data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatology (Oxford) 2006; 45: 1380-4.
27. CLARK CA, SPITZER KA, LASKIN CA: Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005; 32: 1709-12.
28. RAMSEY-GOLDMAN R, KUTZER JE, KULLER LH, GUZICK D, CARPENTER AB, MEDSGER TA JR: Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprodtv Immunol 1992; 28: 195-8.
29. BUYON JP: Dispelling the preconceived nolion that lupus pregnancies result in poor outcomes. J Rheumatol 2005; 32: 1641-2.
30. ALARCON GS, CALVO-ALEN J, MCGWIN G JR et al.: Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 2006; 65: 1168-74.
31. CORTES-HERNANDEZ J, ORDI-ROS J, PAREDES F, CASELLAS M, CASTILLO F, VILARDELL-TARRES M: Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: A prospective study of 103 pregnancies. Rheumatology 2002; 41: 643-50.
32. SOUBASSI L, HAIDOPOULOS D, SINDOS M et al.: Pregnancy outcome in women with preexisting lupus nephritis. J Obstet Gynaecol 2004; 24: 630-4.
33. CHAKRAVARTY EF, COLON I, LANGEN ES et al.: Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005; 192: 1897-904.
34. CERVERA R, FONT J, CARMONA F, BALASCH J: Pregnancy in Systemic Lupus Erythematosus. International Journal of Advances in Rheumatology 2005; 3: 118-23.
35. KITRIDOU RC: The mother in systemic lupus erythematosus. In WALLACE DJ, HAHN BH (Eds.) Dubois' Lupus Erythematosus. Sixth ed. Philadelphia: Lippincott Williams & Wilkins; 2002: 985-1021.
36. DHAR JP, SOKOL CJ: Lupus and pregnancy: complex yet manageable. Clin Med Res 2006; 4: 310-21.